Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Astaxanthin Reduces Exercising Heart Rate by 7% in Overweight Individuals.

NCT05282355 is registered in ClinicalTrials.gov with University of North Alabama as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Astaxanthin Reduces Exercising Heart Rate by 7% in Overweight Individuals.
Lead sponsor
University of North Alabama
Phase
Not applicable
Overall status
Completed
Start date
May 12, 2021
Completion date
July 2, 2021
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic flexibility